MedTrace Logo

Brisk Walking and Baduanjin Improve Inhibitory Function in Older Adults With Cognitive Impairment

NCT07678476 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2026-08-11

No results posted yet for this study

Summary

This study aims to investigate the acute effects of single-session different forms of aerobic exercise (brisk walking and Baduanjin) on inhibitory function and resting-state EEG power in older adults with cognitive impairment, providing scientific evidence for developing exercise intervention programs for this population.

Specifically, this study seeks to answer the following core questions:

1. Can a single session of brisk walking and a single session of Baduanjin exercise improve reaction time and accuracy on the Stroop color-word task in older adults with cognitive impairment?
2. Are there differential effects on inhibitory function between the two exercise modalities?
3. Does a single exercise session induce immediate changes in resting-state EEG power spectrum across multiple frequency bands (δ, θ, α, β)?
4. Are changes in resting-state EEG power associated with improvements in inhibitory function?

Forty-five older adults with cognitive impairment will be randomly assigned to three groups (n=15 each): brisk walking group, Baduanjin group, and control group (quiet seated rest). Participants in the brisk walking and Baduanjin groups will each perform a single 30-minute moderate-intensity exercise session. All participants will complete the Stroop color-word task (assessing reaction time and accuracy under both congruent and incongruent conditions) and undergo a 5-minute eyes-closed resting-state EEG recording before and immediately after the intervention.

Conditions

  • Cognition Impairment

Interventions

BEHAVIORAL

exercise intervention

The brisk walking protocol was designed in accordance with the standards promulgated by the General Administration of Sport of China in 2017. The Baduanjin exercise was based on the "Health Qigong · Baduanjin" protocol promulgated by the General Administration of Sport of China in 2003.

Sponsors & Collaborators

  • Shanghai University of Sport

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-01
Primary Completion
2025-12-30
Completion
2026-04-10

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07678476 on ClinicalTrials.gov